Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

for
Metastatic Tumor
Location: Montreal, London, Vancouver
Sponsor: David Palma

Sex: All

Age: 18+

Code: NCT05717166

Phase3, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Montreal, Ottawa, Quebec, Syracuse NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

for
Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis,
Location: Montreal, Quebec, Toronto, Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05204017

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

for
Amyotrophic Lateral Sclerosis
Location: Montreal, Ottawa
Sponsor: Oliver Blanchard

Sex: All

Age: 18 - 70+

Code: NCT06249867

Phase2, Recruiting

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

for
Clinically Isolated Syndrome,
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18 - 65

Code: NCT05277740

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

for
Amyotrophic Lateral Sclerosis (ALS),
Location: Montreal, Toronto, London, Edmonton
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06351592

Phase1, Phase2, Recruiting

First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

for
Parkinsons Disease
Location: Montreal
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT07216066

Phase1, Recruiting

A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

for
Charcot-Marie-Tooth Disease, Type 1A
Location: Montreal, Sherbrooke, Ottawa
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 60

Code: NCT07140614

Phase1, Recruiting

Study of COYA 302 for the Treatment of ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: Montreal, Boston MA, Toronto, New York NY,
Sponsor: Coya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07161999

Phase2, Phase3, Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

for
Myotonic Dystrophy
Location: Montreal, New York NY, Richmond VA, Gainesville FL,
Sponsor: Sanofi

Sex: All

Age: 10 - 55

Code: NCT06844214

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Montreal, Ottawa, Levis, Foxborough MA, Toronto,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase2, Recruiting

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

for
Hepatocellular Carcinoma
Location: Montreal, Sherbrooke, Toronto, Dothan AL, Duarte CA
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06764316

Phase1, Recruiting

Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic

for
Covid19, Long COVID
Location: Montreal
Sponsor: Emilia Falcone, MD

Sex: All

Age: 18 - 70+

Code: NCT04736732

Recruiting

Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis

for
Cystic Fibrosis
Location: Montreal
Sponsor: Institut de Recherches Cliniques de Montreal

Sex: All

Age: 18+

Code: NCT05099939

Recruiting

Physical Activity to Prevent and Treat Hyperglycemia From a Mistimed Bolus Insulin Dose

for
Type 1 Diabetes Mellitus
Location: Montreal
Sponsor: Jane Yardley

Sex: All

Age: 18 - 24

Code: NCT06686329

Recruiting

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

for
Type1diabetes
Location: Montreal
Sponsor: Institut de Recherches Cliniques de Montreal

Sex: Female

Age: 18 - 50

Code: NCT05258292

Recruiting

Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

for
Type 1 Diabetes, Post-menopause
Location: Montreal, Edmonton
Sponsor: University of Alberta

Sex: Female

Age: 45 - 70+

Code: NCT05188027

Recruiting

Insulin-based Strategies to Prevent Hypoglycemia During Exercise

for
Type 1 Diabetes Mellitus
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 14+

Code: NCT03349489

Recruiting

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

for
Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance,
Location: Montreal
Sponsor: Institut de Recherches Cliniques de Montreal

Sex: All

Age: 45 - 70+

Code: NCT04485871

Recruiting

Taurine Supplementation in Long COVID

for
Long COVID
Location: Montreal, Toronto, Edmonton, Vancouver
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06721949

Phase2, Phase3, Recruiting